Filing Flows › Comparisons › XERS vs MNKD
Xeris Biopharma Holdings vs Mannkind: XERS and MNKD compared
Xeris Biopharma Holdings is the larger company: $107M of revenue in its latest quarter (Q3 2026) against $102M for Mannkind (Q3 2026). Xeris Biopharma Holdings is growing faster (+44% against +24% a year earlier). Xeris Biopharma Holdings is more profitable, with an operating margin of 15.8% against -2.1%.
Where the money goes: XERS and MNKD
Xeris Biopharma Holdings (XERS) · Q3 2026
Xeris Biopharma Holdings, Q3 2026: revenue $107M (+44% year over year), operating margin 15.8%, net earnings $11.3M, operating cash flow $35.5M. The chart follows the revenue to costs, profit and cash.
Mannkind (MNKD) · Q3 2026
Mannkind, Q3 2026: revenue $102M (+24% year over year), operating margin -2.1%, net loss $23.2M, operating cash flow −$34.5M. The chart follows the revenue to costs, profit and cash.
| Xeris Biopharma Holdings (XERS) | Mannkind (MNKD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $107M | $102M |
| Revenue growth, Y/Y | +44% | +24% |
| Operating margin | 15.8% | -2.1% |
| Net earnings | $11.3M | −$23.2M |
| Net margin | 10.5% | -22.8% |
| Operating cash flow | $35.5M | −$34.5M |
| Market value | — | $1.0B |
| Analysts’ mean target | — | $8.11 |
Where the revenue comes from
Xeris Biopharma Holdings
- Product revenue, net: $106M (99%)
- Royalty, contract and other revenue: $958K (1%)
Mannkind
- Product: $45.0M (44%)
- Royalty: $37.5M (37%)
- License and Service: $19.4M (19%)
Questions
Which is bigger, Xeris Biopharma Holdings or Mannkind?
Xeris Biopharma Holdings is the larger company: $107M of revenue in its latest quarter (Q3 2026) against $102M for Mannkind (Q3 2026).
Is Xeris Biopharma Holdings or Mannkind growing faster?
Xeris Biopharma Holdings is growing faster (+44% against +24% a year earlier).
Which is more profitable, Xeris Biopharma Holdings or Mannkind?
Xeris Biopharma Holdings is more profitable, with an operating margin of 15.8% against -2.1%.
More: Xeris Biopharma Holdings earnings · how Xeris Biopharma Holdings makes money · Mannkind earnings · how Mannkind makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.